Biocryst Pharmaceuticals Inc (BCRX)
$8.47 -0.59% Close Oct 30, 2026 Live
Biocryst Pharmaceuticals stock today
Biocryst Pharmaceuticals closed at $8.47 on October 30, 2026, down 0.59% on the day. Over the past year it returned +16.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.15 billion.
$6.00$8.00$10.00
NovJan 2026MarMayJulSep
| Period | BCRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.7% | -0.9% |
| 3 months | -8.3% | +2.1% |
| Year to date | +8.6% | +11.7% |
| 1 year | +16.8% | +12.4% |
| 3 years | +54.3% | +88.5% |
| 5 years | -43.3% | +76.0% |
Key statistics
- Market value
- $2.15B
- Forward P/E
- 10.8
- Price / sales
- 2.3
- 52-week range
- $6.24 to $11.11
- Next report
- Nov 4, 2026
About Biocryst Pharmaceuticals
Discovers and develops small-molecule oral medications for rare diseases.
Sector: Health Care
More on Biocryst Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +94% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $2,061 today
No forecast, no recommendation. This page describes Biocryst Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.